Merck (MRK), Pfizer (PFE) Lilly (LLY) Shares Decline Amid Biotech Weakness
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $129.14 +1.69%
Overall Analyst Rating:
BUY (= Flat)
Dividend Yield: 2.6%
EPS Growth %: +47.9%
Overall Analyst Rating:
BUY (= Flat)
Dividend Yield: 2.6%
EPS Growth %: +47.9%
Join SI Premium – FREE
Merck (NYSE: MRK), Pfizer (NYSE: PFE) Lilly (NYSE: LLY) Shares Decline Amid Biotech Weakness
- Merck -2.2%
- Pfizer -1.8
- Lilly -2.5%
- ETF IBB -2.4%
- ETF XBI -3.3%
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- Merck Announces First-Quarter 2024 Financial Results
- Merck (MRK) April weekly 127 straddle into quarter results
Create E-mail Alert Related Categories
ETFs, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
